–
CRISPR Therapeutics AG
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
374
FY22:
−673
FY23:
−223
FY24:
−467
FY25:
−665
(positive)
Change from FY21 to FY25
millions USD
FY21:
380
FY22:
−651
FY23:
−151
FY24:
−363
FY25:
−578
(positive)
Change from FY21 to FY25
millions USD
FY21:
378
FY22:
−650
FY23:
−154
FY24:
−366
FY25:
−582
All amounts in millions USD